Literature DB >> 11545548

Home intravenous antibiotic therapy programme, 1999.

D Steinmetz1, E Berkovits, H Edelstein, E Flatau, A Almany, R Raz.   

Abstract

OBJECTIVES: To evaluate the cost-effectiveness and safety of the Home Intravenous Antibiotic Therapy (HIAT) program in the district of Haifa and Western Galilee in Northern Israel.
METHODS: We checked all the medical records of all the patients who had been treated at home with intravenous antibiotics during 1999. We reviewed the mean clinical diagnosis, aetiological agent, type of antibiotic given, complications and cost evaluation.
RESULTS: During 1999, 250 patients received 284 courses of HIAT. The total duration of treatments was 3404 days; 61% of the patients were referred from clinical departments from one of the medical centres in our area. Soft-tissue infections and osteomyelitis were the most common clinical diagnoses at 40%. Pseudomonas aeruginosa was the most frequent pathogen presented and Ceftazidine the most common antimicrobial agent prescribed. The HIAT program saved $815 000 during 1999. Only minor complications were present.
CONCLUSIONS: HIAT is effective, safe, comfortable for the patients, and has an important economical impact. Copyright 2001 The British Infection Society.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11545548     DOI: 10.1053/jinf.2001.0824

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  1 in total

1.  Home intravenous antibiotics in a tertiary care hospital in Saudi Arabia.

Authors:  Salim Baharoon; Hind Almodaimeg; Haifa Al Watban; Hamdan Al Jahdali; Thamer Alenazi; Abdullah Al Sayyari; Abdulaziz Al Dawood; Mohammed Al-Sultan; Eiman Al Safi
Journal:  Ann Saudi Med       Date:  2011 Sep-Oct       Impact factor: 1.526

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.